<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6056613</article-id><article-id pub-id-type="doi">10.3389/fimmu.2018.01669</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Susceptibility to Tuberculosis Is Associated With PI3K-Dependent Increased Mobilization of Neutrophils</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Leisching</surname><given-names>Gina R.</given-names></name><xref ref-type="corresp" rid="fn001">*</xref><uri xlink:type="simple" xlink:href="https://frontiersin.org/people/u/398246"/></contrib></contrib-group><aff><institution>DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University</institution>, <addr-line>Cape Town</addr-line>, <country>South Africa</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Deirdre R. Coombe, Curtin University, Australia</p></fn><fn fn-type="edited-by"><p>Reviewed by: Irina V. Lyadova, Central Tuberculosis Research Institute (RAMS), Russia; Raffaella Bonecchi, Humanitas Universit&#x000e0;, Italy</p></fn><corresp id="fn001">*Correspondence: Gina R. Leisching, <email>ginal@sun.ac.za</email></corresp><fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>17</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>1669</elocation-id><history><date date-type="received"><day>16</day><month>4</month><year>2018</year></date><date date-type="accepted"><day>04</day><month>7</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Leisching.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Leisching</copyright-holder><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Neutrophilia is a condition commonly observed in patients with late-stage tuberculosis, but evidence suggests that increased neutrophil influx begins early after infection in susceptible hosts and functions to promote a nutrient-replete niche that promotes <italic>Mycobacterium tuberculosis</italic> survival and persistence. As the disease progresses, an increase in the number of neutrophil-like cells is observed, all of which exhibit characteristics associated with (i) phenotypic and biochemical features of immaturity, (ii) the inability to activate T-cells, (iii) hyper-inflammation, and (iv) prolonged survival. Transcriptomics reveal a common set of molecules associated with the PI3&#x02013;Kinase pathway that are dysregulated in patients with active tuberculosis. Closer inspection of their individual biological roles reveal their ability to modulate the IL-17/G&#x02013;CSF axis, induce leukocyte receptor activation, and regulate apoptosis and motility. This review draws attention to neutrophil hyper-reactivity as a driving force for both the establishment and progression of tuberculosis disease in susceptible individuals.</p></abstract><kwd-group><kwd>neutrophilia</kwd><kwd>tuberculosis</kwd><kwd>susceptibility</kwd><kwd>PI3-kinase</kwd><kwd><italic>Mycobacterium tuberculosis</italic></kwd></kwd-group><funding-group><award-group><funding-source id="cn01">South African Medical Research Council<named-content content-type="fundref-id">10.13039/501100001322</named-content></funding-source></award-group><award-group><funding-source id="cn02">National Research Foundation<named-content content-type="fundref-id">10.13039/501100001321</named-content></funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="0"/><equation-count count="0"/><ref-count count="67"/><page-count count="7"/><word-count count="6029"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Evidence to date suggests a link between the advanced stages of tuberculosis and neutrophilia. In order for neutrophils to accumulate within the lung, an orderly procession of cell&#x02013;endothelial interaction, transcellular or pericellular transmigration, and some degree of enhanced survival or defective egress is required. Overall, evidence points toward a disruption in some of these key events during advanced tuberculosis disease. Multiple studies suggest that neutrophils play a protective role in the prevention of tuberculosis and report antimycobacterial effects in a number of <italic>in vivo</italic> studies (<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B3" ref-type="bibr">3</xref>). It has also been shown that neutrophil-derived bactericidal molecules kill <italic>Mycobacterium tuberculosis in vitro</italic> (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). Human studies further reveal that higher neutrophil counts are protective against early tuberculosis infection (<xref rid="B6" ref-type="bibr">6</xref>), thus during the initial stages infection of infection, neutrophils play a protective role; however, a pathogenic role for neutrophils during the late stages of tuberculosis has been proposed (<xref rid="B7" ref-type="bibr">7</xref>). Neutrophilia has been assigned as a predictor of disease progression, pulmonary destruction, and even death (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B8" ref-type="bibr">8</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>). The neutrophil/lymphocyte ratio (NLR) is able to distinguish tuberculosis patients from tuberculin skin test-positive healthy contacts (<xref rid="B8" ref-type="bibr">8</xref>) and predict pulmonary tuberculosis retreatment (<xref rid="B14" ref-type="bibr">14</xref>). Additionally, the significance of neutrophils during active tuberculosis is highlighted by the fact that the blood transcriptional signature of tuberculosis is neutrophil-driven and effectively distinguishes tuberculosis from other inflammatory diseases (<xref rid="B15" ref-type="bibr">15</xref>). Neutrophils have, however, been shown to mediate an early inflammatory response that is critical for controlling <italic>M. tb</italic> infection. Thus, in the very early stages, evidence suggests that in resistant individuals, neutrophils are likely to control <italic>M. tb</italic> infection in a more effective manner than in susceptible individuals. It should also be noted, however, that not all patients with tuberculosis exhibit neutrophilia. In those that do, it is observed that various sub-sets of neutrophils exist with differing phenotypic characteristics.</p><p>Neutrophil influx to the lung after <italic>M. tb</italic> infection occurs in two phases in susceptible individuals (Figure <xref ref-type="fig" rid="F1">1</xref>): the first phase begins soon after infection and is characterized as T cell-independent, non-specific, and transient with the potential for pathogen clearance (<xref rid="B16" ref-type="bibr">16</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>). The second phase is characterized as T cell-dependant, specific, and ongoing and is associated with disease severity and pathology (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>). During this stage, and as the disease progresses, an increase in the number of neutrophil-like cells (NLC) circulating in the blood and those from lung tissue are observed. They present as immature or undifferentiated precursor cells in the form of myeloid-derived suppressor cells (MDSC) (<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>), tuberculosis-associated neutrophils (TBAN) (<xref rid="B23" ref-type="bibr">23</xref>), low-density neutrophils (<xref rid="B24" ref-type="bibr">24</xref>), and band neutrophils (<xref rid="B20" ref-type="bibr">20</xref>). The role of these precursor/immature neutrophils at the infection site generates a number of questions with regards to their phagocytic abilities. In other words, they are able to phagocytose <italic>M. tb</italic>, but fail to eliminate the bacteria, or they do not phagocytose mycobacteria, but rather associate with T-cells (<xref rid="B25" ref-type="bibr">25</xref>). The mechanisms underlying this second phase of exacerbated neutrophil infiltration into the lungs is largely unknown. During acute infection, in immune-competent individuals, neutrophil chemotaxis is controlled by a fine balance between mitogen-activated protein kinase (p38 MAPK) (<xref rid="B26" ref-type="bibr">26</xref>) and phosphatidylinositol 3-kinase (PI3-K) signaling. Briefly, when neutrophils are activated by chemoattractants, PI3-K phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) into phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which promotes their directional migration (<xref rid="B27" ref-type="bibr">27</xref>). Any perturbations in the expression of these genes coding for components of PI3-K pathway, including its regulators may disrupt neutrophil trafficking and lead to neutrophil hyperreactivity (<xref rid="B28" ref-type="bibr">28</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Neutrophil recruitment into the lung in resistant and susceptible individuals over time in early and advanced stages of <italic>Mycobacterium tuberculosis</italic> infection. In resistant individuals, neutrophil influx occurs soon after infection, where along with macrophages, aid in removing <italic>M. tuberculosis</italic> effectively. Neutrophil numbers return to baseline and a minimal effect on the host is observed. In susceptible individuals, phase I begins soon after infection and is characterized as T cell-independent, non-specific, and transient with the potential for pathogen clearance. Phase II is characterized as T cell-dependant, specific, and ongoing and is associated with disease severity and pathology. During this stage, and as the disease progresses, an increase in the number of neutrophil-like cells (NLC) circulating in the blood and those from lung tissue are observed. They present as immature or undifferentiated precursor cells in the form of myeloid-derived suppressor cells (MDSC), tuberculosis-associated neutrophils (TBAN), low-density neutrophils, and band neutrophils. The second phase of exacerbated neutrophil influx is also associated with lung cavitation and disease progression.</p></caption><graphic xlink:href="fimmu-09-01669-g001"/></fig><p>In this review, attention is drawn to the link between neutrophil hyperreactivity and the progression of tuberculosis disease as a characteristic of the susceptible host. Further, common characteristics of these neutrophils across mouse and human studies are highlighted. A closer look at transcriptomic studies in human and mouse models of tuberculosis reveals altered expression levels of members of the PI3-kinase family and support not only a possible mechanism underpinning neutrophil hyperreactivity but may also explain the ineffectiveness of the adaptive immune response observed during tuberculosis. Using the latest evidence, an attempt is made to elucidate whether enhanced neutrophil trafficking is a function of uncontrolled inflammation or whether specific signals drive neutrophil production during tuberculosis. These mechanisms span over a multitude of cytokines, leukotrienes, complement factors, adaptor molecules, and receptors whose expression may be found ultimately to be dysregulated as a factor of host genetic aberrations.</p></sec><sec id="S2"><title>Susceptibility to Tuberculosis is Associated with a Higher Abundance, Increased Migratory Capacity, and Heterogeneity of Neutrophils</title><p>Immune hyperreactivity underlies the development of tuberculosis disease and is characterized by an over secretion of proinflammatory cytokines and chemokines, exacerbated T cell responses, and increased neutrophil infiltration in the lungs (<xref rid="B20" ref-type="bibr">20</xref>). Neutrophils are the most abundant immune cell found in the bronchoalveolar lavage (BAL) and sputum of active pulmonary tuberculosis patients, and in the lungs are second only to lymphocytes (<xref rid="B9" ref-type="bibr">9</xref>).</p><p>The early immune response to <italic>M. tb</italic> infection is not possible to assess in human subjects; however, mice studies of susceptibility have been able to capture these early immune events with regard to the response of granulocytes soon after mycobacterial infection. Common characteristics of neutrophils from susceptible mouse strains indicate that they have an intrinsically higher migration activity, which does not depend on the presence of an infectious stimulus (<xref rid="B29" ref-type="bibr">29</xref>). It has been observed that in both I/St and DBA/2 susceptible mouse strains, there is a significant influx of neutrophils early on after infection when compared to the resistant strains (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>). Since these mice are bred for susceptibility, this cause of this response is attributed to host-based genetics that are independent of the infectious agent. In both mice and humans, <italic>M. tb</italic> is still not cleared effectively in susceptible hosts, despite the increased number of neutrophils at the infection site. Up until now, it was unknown whether the abundance of neutrophils just days after infection promote <italic>M. tb</italic> survival. Recent work suggests that this hyperreactive influx early on primes the affected tissue for mycobacterial clinical persistence: it was demonstrated that granulocytic inflammation generates a nutrient-replete niche that supports <italic>M. tb</italic> growth, specifically <italic>M. tb</italic> that grow in association with neutrophils encounter a more hospitable environment that is replete with micronutrients, such as iron and lipid carbon sources (<xref rid="B13" ref-type="bibr">13</xref>). This finding proposes that this early influx may promote <italic>M. tb</italic> replication and, therefore, disease progression. A study in patients with recent tuberculosis (patients had not yet received anti-tuberculosis therapy), observed neutrophilia as a common characteristic among patients and a correlation between pulmonary pathology and band neutrophils was confirmed (<xref rid="B20" ref-type="bibr">20</xref>). Generally, elevated band counts (bandemia) suggest serious bacterial infection; however, it is not suggested as parameter for the diagnosis of infection (<xref rid="B31" ref-type="bibr">31</xref>). In the context of early tuberculosis, it may, therefore, be an indication of hyperactivity of the granulocyte response to infection in susceptible individuals. It may, therefore, be inferred that the main difference in the early neutrophil response to <italic>M. tb</italic> infection between susceptible and resistant individuals is (i) the number of neutrophils at the site of infection early post-infection, (ii) the ability of neutrophils to phagocytose, but not eliminate <italic>M. tb</italic> despite these high numbers and finally, (iii) the inability of these neutrophils to effectively communicate with other immune cells to activate an efficient adaptive immune response (discussed below).</p><p>In advanced tuberculosis, neutrophil abundance is an overwhelming feature associated with disease severity. In order to accommodate this influx, other cells, such as the endothelium are also primed as a consequence. It was observed that the endothelial mediators of neutrophil migration, namely <sc>l</sc>-selectin, E-selectin, and ICAM-1 are upregulated in active tuberculosis (<xref rid="B32" ref-type="bibr">32</xref>), which correlates with the observation that neutrophils are present at sites of active mycobacterial disease (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>). Neutrophil trafficking seems to be in-part, associated with the expression of programed death-1 (PDL-1), since PD-1 or PDL-1 knockout mice show exaggerated pathology and excess neutrophil influx (<xref rid="B35" ref-type="bibr">35</xref>). In the case of active tuberculosis, however, PDL-1 is overexpressed by neutrophils (<xref rid="B36" ref-type="bibr">36</xref>), which suggests that either PDL-1 excess or deficiency may result in neutrophil-associated pathology that is linked to exacerbated influx (<xref rid="B18" ref-type="bibr">18</xref>). This effect is likely to be indirect since PDL-1 expression has been shown to inhibit T-cell effector functions during tuberculosis disease (<xref rid="B37" ref-type="bibr">37</xref>) and may explain the delayed accumulation of T-cell responses within the lung that (i) diminish communication between the adaptive and innate immune systems and (ii) prevent clearance of <italic>M. tb</italic>, leading to latency (<xref rid="B38" ref-type="bibr">38</xref>). An interesting concept of &#x0201c;adaptive neutrophils&#x0201d; was introduced through a mouse study of <italic>M. tb</italic> infection where the authors describe that upon the onset of the adaptive immune response, an influx of neutrophils, together with T-cells were recruited to the lung (<xref rid="B25" ref-type="bibr">25</xref>). It is interesting to note that these neutrophils did not associate with the bacteria, but rather interacted closely with T-cells. This non-phagocytic nature is unusual for neutrophils and suggests an altered neutrophil phenotype exists during established disease. The emerging concept of neutrophil heterogeneity that is observed in the blood of tuberculosis patients and mouse studies of <italic>M. tb</italic> infection supports this observation. Both human and mouse models of late-stage infection indicate that the neutrophil population is composed of different subsets that differ in their functional properties, phenotype, and levels of maturity. It is now known that the commensal microbiota regulate steady-state granulopoeisis by regulating G-CSF production (<xref rid="B39" ref-type="bibr">39</xref>), and it has been hypothesized that since neutrophils play a prominent role in containing infections, microbes may dictate multiple aspects of neutrophil biology. A study exemplifying this was based on analyzing the susceptibility of mice preconditioned by mild or severe systemic inflammatory response syndrome (SIRS) to <italic>Staphylococcus aureus</italic> infection (<xref rid="B40" ref-type="bibr">40</xref>). Neutrophils from mice with severe SIRS produce IL-10, are CD49d<sup>neg</sup> CD11b<sup>hi</sup> and uniquely express toll-like receptor-7 (TLR7). In contrast, those neutrophils from mice with mild SIRS are resistant to <italic>S. aureus</italic> and produce IL-12, uniquely express TLR5 and 8, and are CD49d<sup>+</sup>. Further, it was demonstrated that these neutrophil subsets activate macrophages with varying polarity <italic>in vitro</italic>, indicating that these subsets may shape environments, which are microbicidal, inflammatory, or immunosuppressive (<xref rid="B40" ref-type="bibr">40</xref>). More importantly, the presence of neutrophils with immunosuppressive or hyperinflammatory characteristics may underpin the susceptibility to infections.</p><p>Low-density granulocytes (LDG) have recently emerged as one of the subsets found in patients with advanced tuberculosis disease (<xref rid="B24" ref-type="bibr">24</xref>). Transcriptomics reveal that these LDGs exhibit signatures, which correlate best with an immature phenotype, which is based on the expression of mRNA associated with granule enzymes and bactericidal proteins (<xref rid="B41" ref-type="bibr">41</xref>). In the same study, LDGs exhibited decreased phagocytic activity, enhanced survival, and an increased secretion of pro-inflammatory cytokines. The release of these immature neutrophils from the bone marrow is hypothesized to be a result of stress and that the presence of specific cytokines arrests neutrophil maturation (<xref rid="B42" ref-type="bibr">42</xref>). Myeloid-derived suppressor cells (MDSC) are present at higher frequencies in tuberculosis patients when compared to healthy controls and have been shown to have T cell suppressive effects and a higher inflammatory response in coculture (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>). In mice, these MDSCs accumulated in tuberculosis-susceptible mouse strains (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>) and show low Gr-1/Ly-6G expression, which accompanied a significant decrease in the number of the typical Gr-1/Ly-6G<sup>hi</sup> neutrophil phenotype (<xref rid="B23" ref-type="bibr">23</xref>). Evidence suggests that <italic>M. tb</italic> fosters the generation of MDSCs in bone marrow, and that susceptibility to infection and lethal inflammation is associated with systemic accumulation of MDSCs and the presence of MDSC-like cells in the lung parenchyma (<xref rid="B23" ref-type="bibr">23</xref>). Furthermore, it was demonstrated that MDSC accumulation is part of the general inflammatory response to <italic>M. tb</italic> infection and that the dynamics of MDSCs is augmented in a susceptible host developing primary progressive tuberculosis (<xref rid="B22" ref-type="bibr">22</xref>). Both clinical and murine studies agree that these cells phagocytose and &#x0201c;harbor&#x0201d; <italic>M. tb</italic>, suppress T-cell function, and accumulate in susceptible mice/infected individuals during the late stages of tuberculosis disease.</p><p>In studies describing the presence of these neutrophil-like cells found in advanced tuberculosis, it is evident that the total number of &#x0201c;true&#x0201d; neutrophils is reduced, additionally, these neutrophil-like cells have the following characteristics in common, (i) phenotypic and biochemical features of immaturity, (ii) observed to dampen T-cell responses, (iii) hyperinflammatory, and (iv) prolonged survival (discussed below). Chemotactic factors, as well as intracellular signaling promoting directional migration essentially governs the influx of neutrophils to sights of inflammation; however in tuberculosis, aberrant signaling, whether inherent or induced may contribute to the granulocyte hyperreactivity that is observed in susceptible individuals.</p></sec><sec id="S3"><title>The Role of PI3-Kinase Signaling in Shaping the Neutrophil Response</title><p>Disruptions in PI3-kinase signaling can influence a multitude of cells, especially those in which neutrophils play a dominant role. Increased PI3-K activity, in particular, has been shown to compromise the migratory accuracy of neutrophils, thereby prolonging their tissue transit time, which leads to bystander tissue injury mediated by surface-associated neutrophil proteases (<xref rid="B28" ref-type="bibr">28</xref>). Class I PI3-kinases (&#x003b1;, &#x003b2;, &#x003b3;, and &#x003b4;) function to promote the directional migration of neutrophils after activation by chemoattractants (<xref rid="B45" ref-type="bibr">45</xref>). Recently, a study revealed for the first time that PI3-K &#x003b1;, &#x003b2;, and &#x003b4; together orchestrate hematopoietic homeostasis, with PI3-K &#x003b4; being required specifically for leukocyte development (<xref rid="B46" ref-type="bibr">46</xref>). It was further elucidated that deficiencies in PI3-K&#x003b3; and &#x003b4; induced neutrophilia by enhancing signaling through the IL-17/G-CSF axis (<xref rid="B47" ref-type="bibr">47</xref>). Both &#x003b3; and &#x003b4; isoforms have distinct roles in chemokine-induced neutrophil migration (<xref rid="B48" ref-type="bibr">48</xref>). The class II PI3-kinases (C2&#x003b1;, C2&#x003b2;, and C2&#x003b3;) are suggested to play a potential role in agonist-mediated regulation of cellular functions. PI3K-C2&#x003b2; specifically is implicated in the differentiation of hematopoetic cells by retinoic acid (<xref rid="B49" ref-type="bibr">49</xref>). Retrospectively, we observe evidence from blood transcriptional signatures in mouse and human studies of tuberculosis disease, which indicate that circulating neutrophils exhibit altered expression in those genes encoding various PI3-K polypetide/substructures and negative regulators of PI3-K. This will be discussed in more detail below.</p></sec><sec id="S4"><title><italic>PIK3CD</italic> Expression Modulates the IL-17/G-CSF Axis and Neutrophil Chemotaxis in Tuberculosis</title><p>G-CSF drives neutrophil proliferation and differentiation and its secretion is dependent on IL-17 signaling upstream (<xref rid="B50" ref-type="bibr">50</xref>). In response to G-CSF, PI3-K &#x003b4; (<italic>PIK3CD</italic>) produces second messenger signaling molecules, which promote neutrophil movement in response to chemotactic stimuli (<xref rid="B51" ref-type="bibr">51</xref>). Interestingly, PI3-K &#x003b4; has been implicated in intracellular IL-17 signaling (<xref rid="B52" ref-type="bibr">52</xref>) and TH17 cell differentiation (<xref rid="B53" ref-type="bibr">53</xref>). In a mouse study of tuberculosis susceptibility, total lung RNA from two susceptible mouse strains (DBA/2 and CBA/J) was analyzed 4&#x02009;weeks post-infection by Affymetrix GeneChip U74 array (<xref rid="B30" ref-type="bibr">30</xref>). It was observed that <italic>Pik3cd</italic> was significantly upregulated in whole lung tissue, along with <italic>Il17ra</italic> (IL-17 receptor), both of which were not differentially regulated in lung tissue of resistant mouse strains. In the same study, analysis revealed that transcriptomics of the affected lung tissue correlated with excessive neutrophil influx into the lungs and a bias toward the expression of genes involved in granulocyte pathophysiology. Interestingly, another murine study observed that IL-17RA in non-hematopoietic cells (epithelial and endothelial cells, as well as fibroblasts) is critical for neutrophil recruitment to the lung (<xref rid="B25" ref-type="bibr">25</xref>). Evidence also suggests that a decrease/loss in function of PI3-K &#x003b4; also affects IL-17-mediated neutrophil recruitment. This was exemplified in a murine study where it was observed that a deficiency in expression of PI3-K &#x003b4;, along with PI3-K &#x003b3;, enhances the IL-17/G-CSF axis and induces neutrophilia (<xref rid="B47" ref-type="bibr">47</xref>). Additionally, it was noted that a deficiency in these sub-units leads to defective B- and T-cell homeostasis, which underscores their role in effective adaptive immune response activation.</p><p>The intracellular presence of <italic>M. tb</italic> itself also appears to directly affect the expression of <italic>PIK3CD</italic>. A recent study investigated PI3-K &#x003b4; signaling in lung lesions of patients with confirmed pulmonary tuberculosis and observed that the expression of PI3-K &#x003b4; is globally absent throughout tuberculosis granulomas, but present in normal lung tissue from healthy individuals (<xref rid="B54" ref-type="bibr">54</xref>). The same study showed that during early infection, <italic>M. tb</italic> disables the genes encoding PI3-K &#x003b4;/AKT/mTORC1 and MNK regulatory pathways by upregulating a network of microRNAs with sequences targeting the 3&#x02032;UTRs regions (<xref rid="B54" ref-type="bibr">54</xref>). Disruption of this pathway then promotes a tissue-destructive phenotype through MMP-1 upregulation, which promotes lung cavitation. Thus, in granulomas, PI3-K &#x003b4; is absent; however, the authors do not indicate what the level of expression is in the surrounding lung tissue. This finding is supported by another study that showed that the PI3-K pathway is the key regulator of interleukin-17 driven MMP secretion by airway epithelial cells (<xref rid="B55" ref-type="bibr">55</xref>). Evidence from both humans and mice suggests that both a loss and gain in function of <italic>PIK3CD</italic>/PI3-K &#x003b4; leads to disruption of the G-CSF/IL-17 pathway leading to neutrophil hyperreactivity and ineffective communication between the innate and adaptive immune system.</p></sec><sec id="S5"><title><italic>PIK3IP1</italic>, a Negative Regulator PI3-K p110, is Downregulated in Peripheral Leukocytes from Patients with Tuberculosis</title><p>Downstream signaling regulation of the PI3-K pathway is central in maintaining intracellular homeostatic conditions and is controlled by a number of regulators. To date, phosphatase and tensin homolog deleted on chromosome 10 (PTEN), inositol polyphosphate 4-phosphatase type II (INPP4B), and SH2 containing inositol 5&#x02032;-phosphatase (SHIP-1) are well-characterized negative regulators of the PI3-K pathway, all of which act downstream of PI3-K. Recently, PI3-K interacting protein 1 (PIK3IP1) has also been described as a negative regulator of PI3-K and inhibits its activity upstream through proximal allosteric interference with class I PI3K catalytic subunits p110 &#x003b1;, &#x003b2;, and &#x003b4; (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>). To date, there is no information regarding the biological role of PIK3IP1 during tuberculosis infection; however, it may play a part in disruption of the normal life/death time-course of the extravasated neutrophil. Given the propensity of neutrophils to die by &#x0201c;constitutive&#x0201d; apoptosis when utilized for <italic>in vitro</italic> studies, the major challenge in airway research is to determine how and why neutrophils persist in such a large numbers in the lung. Transcriptomics from tuberculosis patients indicate (i) that <italic>PIK3IP1</italic> is part of the transcriptomic signature that discriminates tuberculosis from other inflammatory infections and diseases and (ii) that its expression is downregulated in circulating neutrophils in comparison to healthy controls (<xref rid="B15" ref-type="bibr">15</xref>). Its downregulation was further confirmed in two other whole blood transcriptomic-based tuberculosis studies (<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B59" ref-type="bibr">59</xref>). The consequences of PIK3IP1 on PI3K signaling was elucidated in hepatic cell lines where motility and apoptosis was assessed. It was observed that PIK3IP1 expression suppressed motility and promoted apoptosis in isolated mouse hepatocytes in a PI3-K-dependant manner (<xref rid="B60" ref-type="bibr">60</xref>). Although a similar effect cannot be assumed to occur in the leukocyte, the regulatory role that PIK3IP1 may play in apoptosis and motility cannot be ignored and requires further investigation.</p></sec><sec id="S6"><title><italic>PIK3C2B</italic> is Downregulated in Peripheral Leukocytes from Patients with Tuberculosis</title><p><italic>PIK3C2B</italic> encodes the class II enzymatic isoform C2&#x003b2;, which has a wide tissue distribution and is found to be expressed in lymphocytes. Blood transcriptomics of patients with tuberculosis revealed that that <italic>PIK3C2B</italic> is downregulated when compared to individuals with latent tuberculosis infection (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B59" ref-type="bibr">59</xref>). Little evidence is available regarding the role of this class II PI3K under normal and disease conditions in the context of the whole organism. Interestingly though, studies of <italic>PI3KC2</italic>&#x003b2;<italic>&#x02212;</italic>/<italic>&#x02212;</italic> mice have demonstrated that while <italic>PI3K-C2</italic>&#x003b2;<italic>&#x02212;/&#x02212;</italic> mice exhibit no obvious phenotypic abnormalities (<xref rid="B61" ref-type="bibr">61</xref>), they exhibit increased insulin sensitivity and glucose tolerance, and are resistant to high-fat diet-induced steatosis (<xref rid="B62" ref-type="bibr">62</xref>). Additionally, in the few studies that have been conducted, it appears that C2&#x003b2; generates PI3P, which is essential for receptor activation of various cell types, specifically, the proliferation of T-cells and activation of their TCRs (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>), B-cell receptor signaling (<xref rid="B65" ref-type="bibr">65</xref>), and most recently, mast cell activation through IgE receptor stimulation (<xref rid="B66" ref-type="bibr">66</xref>). Further, pharmacological inhibition of C2&#x003b2; is proposed to have therapeutic potential in diseases, which are IgE-associated (<xref rid="B67" ref-type="bibr">67</xref>). In the context of tuberculosis, however, the average downregulation of this gene across peripheral blood leukocytes in affected individuals suggests an overall dampening of the immune system. Future studies should assess the role of this protein during tuberculosis disease and whether PI3P intracellular levels are affected as this ultimately interferes with receptor activation and as a consequence, communication between the innate and adaptive immune systems.</p></sec><sec id="S7"><title>Concluding Remarks</title><p>Taken together, evidence from both mouse and human studies suggests a strong correlation between neutrophil hyper-reactivity in the tuberculosis-susceptible host. Early infection events indicate a higher-than-average influx of neutrophils to the infection site which appears to facilitate and promote <italic>M. tb</italic> growth (<xref rid="B13" ref-type="bibr">13</xref>). Evidence from transcriptomic studies indicate aberrations in gene expression of key molecules of the PI3-kinase pathway, as well as their regulators during tuberculosis disease. Notable roles of these molecules include modulating the IL-17/G-CSF axis, inducing leukocyte receptor activation, and regulating apoptosis and motility. Thus, the PI3&#x02013;kinase pathway may play an especially prominent role in neutrophils of susceptible individuals and may be an intrinsic cause of tuberculosis disease severity and progression and, therefore, warrants further investigation.</p></sec><sec id="S8"><title>Author Contributions</title><p>The author confirms being the sole contributor of this work and approved it for publication.</p></sec><sec id="S9"><title>Conflict of Interest Statement</title><p>The author declares that the submitted work was carried out with no personal, professional, or financial relationships that could be construed as conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was funded by the South African Medical Research Council and the National Research Foundation of South Africa.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugawara</surname><given-names>I</given-names></name><name><surname>Udagawa</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name></person-group>. <article-title>Rat neutrophils prevent the development of tuberculosis</article-title>. <source>Infect Immun</source> (<year>2004</year>) <volume>72</volume>:<fpage>1804</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.72.3.1804-1806.2004</pub-id><?supplied-pmid 14977991?><pub-id pub-id-type="pmid">14977991</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W-B</given-names></name><name><surname>Kang</surname><given-names>J-S</given-names></name><name><surname>Yan</surname><given-names>J-J</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Jeon</surname><given-names>B-Y</given-names></name><name><surname>Cho</surname><given-names>S-N</given-names></name><etal/></person-group>
<article-title>Neutrophils promote mycobacterial trehalose dimycolate-induced lung inflammation via the Mincle pathway</article-title>. <source>PLoS Pathog</source> (<year>2012</year>) <volume>8</volume>:<fpage>e1002614</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1002614</pub-id><?supplied-pmid 22496642?><pub-id pub-id-type="pmid">22496642</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C-T</given-names></name><name><surname>Cambier</surname><given-names>C</given-names></name><name><surname>Davis</surname><given-names>JM</given-names></name><name><surname>Hall</surname><given-names>CJ</given-names></name><name><surname>Crosier</surname><given-names>PS</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title>Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages</article-title>. <source>Cell Host Microbe</source> (<year>2012</year>) <volume>12</volume>:<fpage>301</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2012.07.009</pub-id><?supplied-pmid 22980327?><pub-id pub-id-type="pmid">22980327</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>GS</given-names></name><name><surname>Amirault</surname><given-names>HJ</given-names></name><name><surname>Andersen</surname><given-names>BR</given-names></name></person-group>. <article-title>Killing of <italic>Mycobacterium tuberculosis</italic> by neutrophils: a nonoxidative process</article-title>. <source>J Infect Dis</source> (<year>1990</year>) <volume>162</volume>:<fpage>700</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/162.3.700</pub-id><?supplied-pmid 2167338?><pub-id pub-id-type="pmid">2167338</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Verma</surname><given-names>I</given-names></name><name><surname>Khuller</surname><given-names>G</given-names></name></person-group>. <article-title>Antibacterial activity of human neutrophil peptide-1 against <italic>Mycobacterium tuberculosis</italic> H37Rv: in vitro and ex vivo study</article-title>. <source>Eur Respir J</source> (<year>2000</year>) <volume>16</volume>:<fpage>112</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1034/j.1399-3003.2000.16a20.x</pub-id><?supplied-pmid 10933095?><pub-id pub-id-type="pmid">10933095</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martineau</surname><given-names>AR</given-names></name><name><surname>Newton</surname><given-names>SM</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Kampmann</surname><given-names>B</given-names></name><name><surname>Hall</surname><given-names>BM</given-names></name><name><surname>Nawroly</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Neutrophil-mediated innate immune resistance to mycobacteria</article-title>. <source>J Clin Invest</source> (<year>2007</year>) <volume>117</volume>:<fpage>1988</fpage>.<pub-id pub-id-type="doi">10.1172/JCI31097</pub-id><?supplied-pmid 17607367?><pub-id pub-id-type="pmid">17607367</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philips</surname><given-names>JA</given-names></name></person-group>. <article-title>Neutrophils: double agents for TB</article-title>. <source>Sci Transl Med</source> (<year>2017</year>) <volume>9</volume>:<fpage>eaan6195</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.aan6195</pub-id><?supplied-pmid 28615363?><pub-id pub-id-type="pmid">28615363</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname><given-names>JS</given-names></name><name><surname>Jeffries</surname><given-names>DJ</given-names></name><name><surname>Donkor</surname><given-names>S</given-names></name><name><surname>Walther</surname><given-names>B</given-names></name><name><surname>Hill</surname><given-names>PC</given-names></name><name><surname>Adetifa</surname><given-names>IM</given-names></name><etal/></person-group>
<article-title>High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting</article-title>. <source>Tuberculosis</source> (<year>2009</year>) <volume>89</volume>:<fpage>398</fpage>&#x02013;<lpage>404</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2009.07.004</pub-id><?supplied-pmid 19683473?><pub-id pub-id-type="pmid">19683473</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eum</surname><given-names>S-Y</given-names></name><name><surname>Kong</surname><given-names>J-H</given-names></name><name><surname>Hong</surname><given-names>M-S</given-names></name><name><surname>Lee</surname><given-names>Y-J</given-names></name><name><surname>Kim</surname><given-names>J-H</given-names></name><name><surname>Hwang</surname><given-names>S-H</given-names></name><etal/></person-group>
<article-title>Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB</article-title>. <source>Chest J</source> (<year>2010</year>) <volume>137</volume>:<fpage>122</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1378/chest.09-0903</pub-id><?supplied-pmid 19749004?><pub-id pub-id-type="pmid">19749004</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Dai</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Xiao</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Multidrug-resistant tuberculosis is associated with low plasma concentrations of human neutrophil peptides 1&#x02013;3</article-title>. <source>Int J Tuberc Lung Dis</source> (<year>2011</year>) <volume>15</volume>:<fpage>369</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">21333105</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>DM</given-names></name><name><surname>Bandara</surname><given-names>AK</given-names></name><name><surname>Packe</surname><given-names>GE</given-names></name><name><surname>Barker</surname><given-names>RD</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Griffiths</surname><given-names>CJ</given-names></name><etal/></person-group>
<article-title>Neutrophilia independently predicts death in tuberculosis</article-title>. <source>Eur Respir J</source> (<year>2013</year>) <volume>42</volume>:<fpage>1752</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1183/09031936.00140913</pub-id><pub-id pub-id-type="pmid">24114967</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>CW</given-names></name><name><surname>Elkington</surname><given-names>PT</given-names></name><name><surname>Brilha</surname><given-names>S</given-names></name><name><surname>Ugarte-Gil</surname><given-names>C</given-names></name><name><surname>Tome-Esteban</surname><given-names>MT</given-names></name><name><surname>Tezera</surname><given-names>LB</given-names></name><etal/></person-group>
<article-title>Neutrophil-derived MMP-8 drives AMPK-dependent matrix destruction in human pulmonary tuberculosis</article-title>. <source>PLoS Pathog</source> (<year>2015</year>) <volume>11</volume>:<fpage>e1004917</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1004917</pub-id><?supplied-pmid 25996154?><pub-id pub-id-type="pmid">25996154</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>BB</given-names></name><name><surname>Lovewell</surname><given-names>RR</given-names></name><name><surname>Olive</surname><given-names>AJ</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Eugenin</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis</article-title>. <source>Nat Microbiol</source> (<year>2017</year>) <volume>2</volume>:<fpage>17072</fpage>.<pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.72</pub-id><?supplied-pmid 28504669?><pub-id pub-id-type="pmid">28504669</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Kuai</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Shan</surname><given-names>Z</given-names></name><name><surname>Gu</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Pretreatment neutrophil-to-lymphocyte ratio in peripheral blood was associated with pulmonary tuberculosis retreatment</article-title>. <source>Arch Med Sci: AMS</source> (<year>2017</year>) <volume>13</volume>:<fpage>404</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.5114/aoms.2016.60822</pub-id><?supplied-pmid 28261295?><pub-id pub-id-type="pmid">28261295</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source> (<year>2010</year>) <volume>466</volume>:<fpage>973</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedrosa</surname><given-names>J</given-names></name><name><surname>Saunders</surname><given-names>BM</given-names></name><name><surname>Appelberg</surname><given-names>R</given-names></name><name><surname>Orme</surname><given-names>IM</given-names></name><name><surname>Silva</surname><given-names>MT</given-names></name><name><surname>Cooper</surname><given-names>AM</given-names></name></person-group>. <article-title>Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice</article-title>. <source>Infect Immun</source> (<year>2000</year>) <volume>68</volume>:<fpage>577</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.68.2.577-583.2000</pub-id><?supplied-pmid 10639420?><pub-id pub-id-type="pmid">10639420</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulton</surname><given-names>S</given-names></name><name><surname>Reba</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>T</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name></person-group>. <article-title>Neutrophil-mediated mycobacteriocidal immunity in the lung during <italic>Mycobacterium bovis</italic> BCG infection in C57BL/6 mice</article-title>. <source>Infect Immun</source> (<year>2002</year>) <volume>70</volume>:<fpage>5322</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.70.9.5322-5327.2002</pub-id><?supplied-pmid 12183593?><pub-id pub-id-type="pmid">12183593</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>DM</given-names></name><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name><name><surname>Martineau</surname><given-names>AR</given-names></name></person-group>. <article-title>Neutrophils in tuberculosis: friend or foe?</article-title>
<source>Trends Immunol</source> (<year>2012</year>) <volume>33</volume>:<fpage>14</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2011.10.003</pub-id><?supplied-pmid 22094048?><pub-id pub-id-type="pmid">22094048</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyadova</surname><given-names>IV</given-names></name></person-group>. <article-title>Neutrophils in tuberculosis: heterogeneity shapes the way?</article-title>
<source>Mediators Inflamm</source> (<year>2017</year>) <volume>2017</volume>:<fpage>8619307</fpage>.<pub-id pub-id-type="doi">10.1155/2017/8619307</pub-id><?supplied-pmid 28626346?><pub-id pub-id-type="pmid">28626346</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panteleev</surname><given-names>AV</given-names></name><name><surname>Nikitina</surname><given-names>IY</given-names></name><name><surname>Burmistrova</surname><given-names>IA</given-names></name><name><surname>Kosmiadi</surname><given-names>GA</given-names></name><name><surname>Radaeva</surname><given-names>TV</given-names></name><name><surname>Amansahedov</surname><given-names>RB</given-names></name><etal/></person-group>
<article-title>Severe tuberculosis in humans correlates best with neutrophil abundance and lymphocyte deficiency and does not correlate with antigen-specific CD4 T-cell response</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<fpage>963</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2017.00963</pub-id><?supplied-pmid 28871253?><pub-id pub-id-type="pmid">28871253</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obreg&#x000f3;n-Henao</surname><given-names>A</given-names></name><name><surname>Henao-Tamayo</surname><given-names>M</given-names></name><name><surname>Orme</surname><given-names>IM</given-names></name><name><surname>Ordway</surname><given-names>DJ</given-names></name></person-group>
<article-title>Gr1intCD11b+ myeloid-derived suppressor cells in <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e80669</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0080669</pub-id><pub-id pub-id-type="pmid">24224058</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knaul</surname><given-names>JK</given-names></name><name><surname>J&#x000f6;rg</surname><given-names>S</given-names></name><name><surname>Oberbeck-Mueller</surname><given-names>D</given-names></name><name><surname>Heinemann</surname><given-names>E</given-names></name><name><surname>Scheuermann</surname><given-names>L</given-names></name><name><surname>Brinkmann</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2014</year>) <volume>190</volume>:<fpage>1053</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201405-0828OC</pub-id><?supplied-pmid 25275852?><pub-id pub-id-type="pmid">25275852</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsiganov</surname><given-names>EN</given-names></name><name><surname>Verbina</surname><given-names>EM</given-names></name><name><surname>Radaeva</surname><given-names>TV</given-names></name><name><surname>Sosunov</surname><given-names>VV</given-names></name><name><surname>Kosmiadi</surname><given-names>GA</given-names></name><name><surname>Nikitina</surname><given-names>IY</given-names></name><etal/></person-group>
<article-title>Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<fpage>4718</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1301365</pub-id><?supplied-pmid 24711621?><pub-id pub-id-type="pmid">24711621</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Low-density granulocytes are elevated in mycobacterial infection and associated with the severity of tuberculosis</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0153567</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0153567</pub-id><?supplied-pmid 27073889?><pub-id pub-id-type="pmid">27073889</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombard</surname><given-names>R</given-names></name><name><surname>Doz</surname><given-names>E</given-names></name><name><surname>Carreras</surname><given-names>F</given-names></name><name><surname>Epardaud</surname><given-names>M</given-names></name><name><surname>Le Vern</surname><given-names>Y</given-names></name><name><surname>Buzoni-Gatel</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>IL-17RA in non-hematopoietic cells controls CXCL-1 and 5 critical to recruit neutrophils to the lung of mycobacteria-infected mice during the adaptive immune response</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0149455</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0149455</pub-id><?supplied-pmid 26871571?><pub-id pub-id-type="pmid">26871571</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heit</surname><given-names>B</given-names></name><name><surname>Robbins</surname><given-names>SM</given-names></name><name><surname>Downey</surname><given-names>CM</given-names></name><name><surname>Guan</surname><given-names>Z</given-names></name><name><surname>Colarusso</surname><given-names>P</given-names></name><name><surname>Miller</surname><given-names>BJ</given-names></name><etal/></person-group>
<article-title>PTEN functions to &#x02018;prioritize&#x02019; chemotactic cues and prevent &#x02018;distraction&#x02019; in migrating neutrophils</article-title>. <source>Nat Immunol</source> (<year>2008</year>) <volume>9</volume>:<fpage>743</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1038/ni.1623</pub-id><?supplied-pmid 18536720?><pub-id pub-id-type="pmid">18536720</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funamoto</surname><given-names>S</given-names></name><name><surname>Meili</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Parry</surname><given-names>L</given-names></name><name><surname>Firtel</surname><given-names>RA</given-names></name></person-group>. <article-title>Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis</article-title>. <source>Cell</source> (<year>2002</year>) <volume>109</volume>:<fpage>611</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1016/S0092-8674(02)00755-9</pub-id><?supplied-pmid 12062104?><pub-id pub-id-type="pmid">12062104</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapey</surname><given-names>E</given-names></name><name><surname>Greenwood</surname><given-names>H</given-names></name><name><surname>Walton</surname><given-names>G</given-names></name><name><surname>Mann</surname><given-names>E</given-names></name><name><surname>Love</surname><given-names>A</given-names></name><name><surname>Aaronson</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence</article-title>. <source>Blood</source> (<year>2014</year>) <volume>123</volume>:<fpage>239</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2013-08-519520</pub-id><?supplied-pmid 24191150?><pub-id pub-id-type="pmid">24191150</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eruslanov</surname><given-names>EB</given-names></name><name><surname>Lyadova</surname><given-names>IV</given-names></name><name><surname>Kondratieva</surname><given-names>TK</given-names></name><name><surname>Majorov</surname><given-names>KB</given-names></name><name><surname>Scheglov</surname><given-names>IV</given-names></name><name><surname>Orlova</surname><given-names>MO</given-names></name><etal/></person-group>
<article-title>Neutrophil responses to <italic>Mycobacterium tuberculosis</italic> infection in genetically susceptible and resistant mice</article-title>. <source>Infect Immun</source> (<year>2005</year>) <volume>73</volume>:<fpage>1744</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.73.3.1744-1753.2005</pub-id><?supplied-pmid 15731075?><pub-id pub-id-type="pmid">15731075</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>C</given-names></name><name><surname>Hoffmann</surname><given-names>R</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name><name><surname>Brandau</surname><given-names>S</given-names></name><name><surname>Hermann</surname><given-names>C</given-names></name><name><surname>Ehlers</surname><given-names>S</given-names></name></person-group>. <article-title>Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes</article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>:<fpage>4295</fpage>&#x02013;<lpage>309</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00057-06</pub-id><?supplied-pmid 16790804?><pub-id pub-id-type="pmid">16790804</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornbleet</surname><given-names>PJ</given-names></name></person-group>. <article-title>Clinical utility of the band count</article-title>. <source>Clin Lab Med</source> (<year>2002</year>) <volume>22</volume>:<fpage>101</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1016/S0272-2712(03)00069-6</pub-id><?supplied-pmid 11933571?><pub-id pub-id-type="pmid">11933571</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukae</surname><given-names>H</given-names></name><name><surname>Ashitani</surname><given-names>J.i</given-names></name><name><surname>Tokojima</surname><given-names>M</given-names></name><name><surname>Ihi</surname><given-names>T</given-names></name><name><surname>Kohno</surname><given-names>S</given-names></name><name><surname>Matsukura</surname><given-names>S</given-names></name></person-group>. <article-title>Elevated levels of circulating adhesion molecules in patients with active pulmonary tuberculosis</article-title>. <source>Respirology</source> (<year>2003</year>) <volume>8</volume>:<fpage>326</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1046/j.1440-1843.2003.00471.x</pub-id><?supplied-pmid 12911826?><pub-id pub-id-type="pmid">12911826</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condos</surname><given-names>R</given-names></name><name><surname>Rom</surname><given-names>WN</given-names></name><name><surname>Liu</surname><given-names>YM</given-names></name><name><surname>Schluger</surname><given-names>NW</given-names></name></person-group>. <article-title>Local immune responses correlate with presentation and outcome in tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>1998</year>) <volume>157</volume>:<fpage>729</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1164/ajrccm.157.3.9705044</pub-id><?supplied-pmid 9517583?><pub-id pub-id-type="pmid">9517583</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashitani</surname><given-names>J.-i</given-names></name><name><surname>Mukae</surname><given-names>H</given-names></name><name><surname>Hiratsuka</surname><given-names>T</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name><name><surname>Kumamoto</surname><given-names>K</given-names></name><name><surname>Matsukura</surname><given-names>S</given-names></name></person-group>
<article-title>Elevated levels of &#x003b1;-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis</article-title>. <source>Chest</source> (<year>2002</year>) <volume>121</volume>:<fpage>519</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1378/chest.121.2.519</pub-id><pub-id pub-id-type="pmid">11834667</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Sharpe</surname><given-names>AH</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group>
<article-title>CD4 T cells promote rather than control tuberculosis in the absence of PD-1&#x02013;mediated inhibition</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<fpage>1598</fpage>&#x02013;<lpage>607</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1003304</pub-id><pub-id pub-id-type="pmid">21172867</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><etal/></person-group>
<article-title>Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis</article-title>. <source>Eur J Immunol</source> (<year>2011</year>) <volume>41</volume>:<fpage>1941</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201141421</pub-id><pub-id pub-id-type="pmid">21509782</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurado</surname><given-names>JO</given-names></name><name><surname>Alvarez</surname><given-names>IB</given-names></name><name><surname>Pasquinelli</surname><given-names>V</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>GJ</given-names></name><name><surname>Quiroga</surname><given-names>MF</given-names></name><name><surname>Abbate</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Programmed death (PD)-1: PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>:<fpage>116</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.181.1.116</pub-id><?supplied-pmid 18566376?><pub-id pub-id-type="pmid">18566376</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medlar</surname><given-names>EM</given-names></name></person-group>
<article-title>The behavior of pulmonary tuberculous lesions; a pathological study</article-title>. <source>Am Rev Tuberc</source> (<year>1955</year>) <volume>71</volume>:<fpage>1</fpage>.</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bugl</surname><given-names>S</given-names></name><name><surname>Wirths</surname><given-names>S</given-names></name><name><surname>Radsak</surname><given-names>MP</given-names></name><name><surname>Schild</surname><given-names>H</given-names></name><name><surname>Stein</surname><given-names>P</given-names></name><name><surname>Andr&#x000e9;</surname><given-names>MC</given-names></name><etal/></person-group>
<article-title>Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling</article-title>. <source>Blood</source> (<year>2013</year>) <volume>121</volume>:<fpage>723</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2012-05-429589</pub-id><?supplied-pmid 23223360?><pub-id pub-id-type="pmid">23223360</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuda</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Hanafusa</surname><given-names>T</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name><name><surname>Suzuki</surname><given-names>F</given-names></name></person-group>. <article-title>Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant <italic>Staphylococcus aureus</italic></article-title>. <source>Immunity</source> (<year>2004</year>) <volume>21</volume>:<fpage>215</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2004.07.006</pub-id><?supplied-pmid 15308102?><pub-id pub-id-type="pmid">15308102</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>HL</given-names></name><name><surname>Makki</surname><given-names>FA</given-names></name><name><surname>Moots</surname><given-names>RJ</given-names></name><name><surname>Edwards</surname><given-names>SW</given-names></name></person-group>
<article-title>Low-density granulocytes: functionally distinct, immature neutrophils in rheumatoid arthritis with altered properties and defective TNF signalling</article-title>. <source>J Leukoc Biol</source> (<year>2017</year>) <volume>101</volume>:<fpage>599</fpage>&#x02013;<lpage>611</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.5A0116-022R</pub-id><pub-id pub-id-type="pmid">27601627</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Carmona-Rivera</surname><given-names>C</given-names></name><name><surname>Kaplan</surname><given-names>MJ</given-names></name></person-group>
<article-title>Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity</article-title>. In: <person-group person-group-type="editor"><name><surname>Hasler</surname><given-names>P</given-names></name><name><surname>Hahn</surname><given-names>S</given-names></name></person-group>, editors. <source>Seminars in Immunopathology</source>. <publisher-name>Springer</publisher-name> (<year>2013</year>). p. <fpage>455</fpage>&#x02013;<lpage>63</lpage>.</mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>du Plessis</surname><given-names>N</given-names></name><name><surname>Loebenberg</surname><given-names>L</given-names></name><name><surname>Kriel</surname><given-names>M</given-names></name><name><surname>von Groote-Bidlingmaier</surname><given-names>F</given-names></name><name><surname>Ribechini</surname><given-names>E</given-names></name><name><surname>Loxton</surname><given-names>AG</given-names></name><etal/></person-group>
<article-title>Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2013</year>) <volume>188</volume>:<fpage>724</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201302-0249OC</pub-id><?supplied-pmid 23885784?><pub-id pub-id-type="pmid">23885784</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Daker</surname><given-names>S</given-names></name><name><surname>Sacchi</surname><given-names>A</given-names></name><name><surname>Tempestilli</surname><given-names>M</given-names></name><name><surname>Carducci</surname><given-names>C</given-names></name><name><surname>Goletti</surname><given-names>D</given-names></name><name><surname>Vanini</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Granulocytic myeloid derived suppressor cells expansion during active pulmonary tuberculosis is associated with high nitric oxide plasma level</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0123772</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0123772</pub-id><?supplied-pmid 25879532?><pub-id pub-id-type="pmid">25879532</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolaczkowska</surname><given-names>E</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group>. <article-title>Neutrophil recruitment and function in health and inflammation</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>13</volume>:<fpage>159</fpage>.<pub-id pub-id-type="doi">10.1038/nri3399</pub-id><?supplied-pmid 23435331?><pub-id pub-id-type="pmid">23435331</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palam</surname><given-names>LR</given-names></name><name><surname>Mali</surname><given-names>R</given-names></name><name><surname>Ramdas</surname><given-names>B</given-names></name><name><surname>Vanhaesebroeck</surname><given-names>B</given-names></name><name><surname>Kapur</surname><given-names>R</given-names></name></person-group>
<article-title>PI3Kinase inactivation through combined loss of catalytic subunits p110&#x003b1;, p110&#x003b2; and p110&#x003b4; derails hematopoietic homeostasis</article-title>. <source>Am Soc Hematol</source> (<year>2017</year>) <volume>130</volume>:<fpage>3754</fpage>.</mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucher</surname><given-names>K</given-names></name><name><surname>Schmitt</surname><given-names>F</given-names></name><name><surname>Mothes</surname><given-names>B</given-names></name><name><surname>Blumendeller</surname><given-names>C</given-names></name><name><surname>Sch&#x000e4;ll</surname><given-names>D</given-names></name><name><surname>Piekorz</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Deficiency of PI3-kinase catalytic isoforms p110&#x003b3; and p110&#x003b4; in mice enhances the IL-17/G-CSF axis and induces neutrophilia</article-title>. <source>Cell Commun Signal</source> (<year>2017</year>) <volume>15</volume>:<fpage>28</fpage>.<pub-id pub-id-type="doi">10.1186/s12964-017-0185-y</pub-id><?supplied-pmid 28724384?><pub-id pub-id-type="pmid">28724384</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Puri</surname><given-names>KD</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group>
<article-title>Leukocyte PI3K&#x003b3; and PI3K&#x003b4; have temporally distinct roles for leukocyte recruitment in vivo</article-title>. <source>Blood</source> (<year>2007</year>) <volume>110</volume>:<fpage>1191</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2006-11-060103</pub-id><pub-id pub-id-type="pmid">17488877</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vi&#x00161;nji&#x00107;</surname><given-names>D</given-names></name><name><surname>Crljen</surname><given-names>V</given-names></name><name><surname>&#x00106;uri&#x00107;</surname><given-names>J</given-names></name><name><surname>Batini&#x00107;</surname><given-names>D</given-names></name><name><surname>Volinia</surname><given-names>S</given-names></name><name><surname>Banfi&#x00107;</surname><given-names>H</given-names></name></person-group>
<article-title>The activation of nuclear phosphoinositide 3-kinase C2&#x003b2; in all-trans-retinoic acid-differentiated HL-60 cells</article-title>. <source>FEBS Lett</source> (<year>2002</year>) <volume>529</volume>:<fpage>268</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1016/S0014-5793(02)03357-4</pub-id><pub-id pub-id-type="pmid">12372612</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarzenberger</surname><given-names>P</given-names></name><name><surname>La Russa</surname><given-names>V</given-names></name><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Ye</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Zieske</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines</article-title>. <source>J Immunol</source> (<year>1998</year>) <volume>161</volume>:<fpage>6383</fpage>&#x02013;<lpage>9</lpage>.<?supplied-pmid 9834129?><pub-id pub-id-type="pmid">9834129</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadhu</surname><given-names>C</given-names></name><name><surname>Masinovsky</surname><given-names>B</given-names></name><name><surname>Dick</surname><given-names>K</given-names></name><name><surname>Sowell</surname><given-names>CG</given-names></name><name><surname>Staunton</surname><given-names>DE</given-names></name></person-group>
<article-title>Essential role of phosphoinositide 3-kinase &#x003b4; in neutrophil directional movement</article-title>. <source>J Immunol</source> (<year>2003</year>) <volume>170</volume>:<fpage>2647</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.170.5.2647</pub-id><pub-id pub-id-type="pmid">12594293</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>SJ</given-names></name><name><surname>Ciuclan</surname><given-names>L</given-names></name><name><surname>Finan</surname><given-names>PM</given-names></name><name><surname>Wymann</surname><given-names>MP</given-names></name><name><surname>Walker</surname><given-names>C</given-names></name><name><surname>Westwick</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Genetic ablation of PI3K&#x003b3; results in defective IL-17RA signalling in T lymphocytes and increased IL-17 levels</article-title>. <source>Eur J Immunol</source> (<year>2012</year>) <volume>42</volume>:<fpage>3394</fpage>&#x02013;<lpage>404</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201242463</pub-id><pub-id pub-id-type="pmid">22930133</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergamini</surname><given-names>G</given-names></name><name><surname>Bell</surname><given-names>K</given-names></name><name><surname>Shimamura</surname><given-names>S</given-names></name><name><surname>Werner</surname><given-names>T</given-names></name><name><surname>Cansfield</surname><given-names>A</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>A selective inhibitor reveals PI3K&#x003b3; dependence of T H 17 cell differentiation</article-title>. <source>Nat Chem Biol</source> (<year>2012</year>) <volume>8</volume>:<fpage>576</fpage><pub-id pub-id-type="doi">10.1038/nchembio.957</pub-id><pub-id pub-id-type="pmid">22544264</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brace</surname><given-names>PT</given-names></name><name><surname>Tezera</surname><given-names>LB</given-names></name><name><surname>Bielecka</surname><given-names>MK</given-names></name><name><surname>Mellows</surname><given-names>T</given-names></name><name><surname>Garay</surname><given-names>D</given-names></name><name><surname>Tian</surname><given-names>S</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> subverts negative regulatory pathways in human macrophages to drive immunopathology</article-title>. <source>PLoS Pathog</source> (<year>2017</year>) <volume>13</volume>:<fpage>e1006367</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1006367</pub-id><?supplied-pmid 28570642?><pub-id pub-id-type="pmid">28570642</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Elkington</surname><given-names>P</given-names></name><name><surname>Gardiner</surname><given-names>H</given-names></name><name><surname>Saraiva</surname><given-names>L</given-names></name><name><surname>Friedland</surname><given-names>J</given-names></name></person-group>
<article-title>Modulation of metalloproteinase activity in tuberculosis by Interleukin-17 and anti-tuberculous drugs</article-title>. <source>J Infect</source> (<year>2009</year>) <volume>59</volume>:<fpage>S437</fpage><pub-id pub-id-type="doi">10.1016/j.jinf.2009.10.023</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Stoops</surname><given-names>J</given-names></name><name><surname>Eaker</surname><given-names>AE</given-names></name><name><surname>Stoffer</surname><given-names>DS</given-names></name><etal/></person-group>
<article-title>PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2007</year>) <volume>358</volume>:<fpage>66</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbrc.2007.04.096</pub-id><?supplied-pmid 17475214?><pub-id pub-id-type="pmid">17475214</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uche</surname><given-names>UN</given-names></name><name><surname>Kane</surname><given-names>LP</given-names></name></person-group>
<article-title>PIK3IP1-a novel negative regulator of PI3K</article-title>. <source>Am Assoc Immnol</source> (<year>2016</year>) <volume>196</volume>(<issue>1 Supplement</issue>):<fpage>57.9</fpage>.</mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Repsilber</surname><given-names>D</given-names></name><name><surname>Parida</surname><given-names>SK</given-names></name><name><surname>Stanley</surname><given-names>K</given-names></name><name><surname>Roberts</surname><given-names>T</given-names></name><name><surname>Black</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Human gene expression profiles of susceptibility and resistance in tuberculosis</article-title>. <source>Genes Immun</source> (<year>2011</year>) <volume>12</volume>:<fpage>15</fpage>.<pub-id pub-id-type="doi">10.1038/gene.2010.51</pub-id><?supplied-pmid 20861863?><pub-id pub-id-type="pmid">20861863</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Weiner</surname><given-names>J</given-names></name><name><surname>Mollenkopf</surname><given-names>H-J</given-names></name><name><surname>Network</surname><given-names>T</given-names></name><name><surname>Bauer</surname><given-names>T</given-names></name><name><surname>Prasse</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Common patterns and disease-related signatures in tuberculosis and sarcoidosis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2012</year>) <volume>109</volume>:<fpage>7853</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1121072109</pub-id><?supplied-pmid 22547807?><pub-id pub-id-type="pmid">22547807</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Stoops</surname><given-names>J</given-names></name><name><surname>Eaker</surname><given-names>AE</given-names></name><name><surname>Bowen</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma</article-title>. <source>Cancer Res</source> (<year>2008</year>) <volume>68</volume>:<fpage>5591</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-0025</pub-id><?supplied-pmid 18632611?><pub-id pub-id-type="pmid">18632611</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname><given-names>K</given-names></name><name><surname>Truong</surname><given-names>AB</given-names></name><name><surname>Cai</surname><given-names>T</given-names></name><name><surname>Khavari</surname><given-names>PA</given-names></name></person-group>
<article-title>The class II phosphoinositide 3-kinase C2&#x003b2; is not essential for epidermal differentiation</article-title>. <source>Mol Cell Biol</source> (<year>2005</year>) <volume>25</volume>:<fpage>11122</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1128/MCB.25.24.11122-11130.2005</pub-id><pub-id pub-id-type="pmid">16314532</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alliouachene</surname><given-names>S</given-names></name><name><surname>Bilanges</surname><given-names>B</given-names></name><name><surname>Chicanne</surname><given-names>G</given-names></name><name><surname>Anderson</surname><given-names>KE</given-names></name><name><surname>Pearce</surname><given-names>W</given-names></name><name><surname>Ali</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Inactivation of the class II PI3K-C2&#x003b2; potentiates insulin signaling and sensitivity</article-title>. <source>Cell Rep</source> (<year>2015</year>) <volume>13</volume>:<fpage>1881</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/j.celrep.2015.10.052</pub-id><?supplied-pmid 26655903?><pub-id pub-id-type="pmid">26655903</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Srivastava</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Zuvela-Jelaska</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2&#x003b2;</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2011</year>) <volume>108</volume>:<fpage>20072</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1111233109</pub-id><?supplied-pmid 22128329?><pub-id pub-id-type="pmid">22128329</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balzarotti</surname><given-names>G</given-names></name><name><surname>Tibolla</surname><given-names>G</given-names></name><name><surname>Bonacina</surname><given-names>F</given-names></name><name><surname>D&#x02019;Alonzo</surname><given-names>C</given-names></name><name><surname>Dhyani</surname><given-names>A</given-names></name><name><surname>Falasca</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>PI3K-C2B plays a key role in the activation and the proliferation of t lymphocytes: impact on vascular diseases</article-title>. <source>Atherosclerosis</source> (<year>2015</year>) <volume>241</volume>:<fpage>e35</fpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2015.04.127</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>BA</given-names></name><name><surname>Yancopoulos</surname><given-names>S</given-names></name><name><surname>Tipping</surname><given-names>M</given-names></name><name><surname>Yan</surname><given-names>X.-j</given-names></name><name><surname>Wang</surname><given-names>XP</given-names></name><name><surname>Bennett</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes</article-title>. <source>Immunol Res</source> (<year>2015</year>) <volume>63</volume>:<fpage>90</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="doi">10.1007/s12026-015-8688-3</pub-id><?supplied-pmid 26318878?><pub-id pub-id-type="pmid">26318878</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Skolnik</surname><given-names>EY</given-names></name></person-group>. <article-title>Phosphatidlyinositol-3-kinase C2 beta (PI3KC2&#x003b2;) is a potential new target to treat IgE mediated disease</article-title>. <source>PLoS One</source> (<year>2017</year>) <volume>12</volume>:<fpage>e0183474</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0183474</pub-id><?supplied-pmid 28820911?><pub-id pub-id-type="pmid">28820911</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Shah</surname><given-names>R</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name></person-group>. <article-title>Targeting mast cells: uncovering prolific therapeutic role in myriad diseases</article-title>. <source>Int Immunopharmacol</source> (<year>2016</year>) <volume>40</volume>:<fpage>362</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/j.intimp.2016.09.019</pub-id><?supplied-pmid 27694038?><pub-id pub-id-type="pmid">27694038</pub-id></mixed-citation></ref></ref-list></back></article>